Frontline Pharma: Sarah O’Keeffe - Takeaways - MDSpire
Feature

Frontline Pharma: Sarah O’Keeffe

Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients

  • By

  • James Strachan

  • May 8, 2026

  • 16 min

Share

  • 1

    FDA approved Eli Lilly's orforglipron as a new obesity medication.

  • 2

    The development process was enhanced for efficiency and sustainability.

  • 3

    Sarah O’Keeffe leads a diverse team of 1500 scientists at Lilly.

  • 4

    O’Keeffe will present at HPLC 2026 discussing complex drug development.

  • 5

    Collaboration across disciplines is vital for pharmaceutical innovation.

  • 6

    The Lilly Medicine Foundry is a cutting-edge facility supporting drug development.

Original Source(s)

Frontline Pharma: Sarah O’Keeffe

  • by James Strachan

  • May 8, 2026

Related Content

Ancient DNA Tracks 10,000 Years of Selection

Large dataset shows widespread genetic changes shaping modern traits and disease risk

  • May 12, 2026

  • 3 min
Remote Diet Support Studied in Diabetes

WhatsApp-based low-carbohydrate nutrition education was linked to short-term glycemic, weight, and medication-use improvements in a small primary care trial

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.